Should we still be performing macular laser for non-centre involving diabetic macular oedema? No
- PMID: 34645965
- PMCID: PMC8873404
- DOI: 10.1038/s41433-021-01787-5
Should we still be performing macular laser for non-centre involving diabetic macular oedema? No
Conflict of interest statement
SJT: advisory board for Bayer and Novartis; speaker fees from Bayer and Novartis; involved in research with Bayer, Novartis, Roche and Boehringer Ingelheim. The remaining author declares no competing interests.
References
-
- Focal Photocoagulation Treatment of Diabetic Macular Edema: Relationship of Treatment Effect to Fluorescein Angiographic and Other Retinal Characteristics at Baseline: ETDRS Report No. 19. Arch Ophthalmol. 1995;113:1144–55. - PubMed
-
- Baker CW, Glassman AR, Beaulieu WT, Antoszyk AN, Browning DJ, Chalam KV, et al. DRCR Retina Network. Effect of initial management with aflibercept vs laser photocoagulation vs observation on vision loss among patients with diabetic macular edema involving the center of the macula and good visual acuity: a randomized clinical trial. JAMA. 2019;321:1880–94. doi: 10.1001/jama.2019.5790. - DOI - PMC - PubMed
-
- Busch C, Fraser-Bell S, Zur D, Rodríguez-Valdés PJ, Cebeci Z, Lupidi M, et al. International Retina Group. Real-world outcomes of observation and treatment in diabetic macular edema with very good visual acuity: the OBTAIN study. Acta Diabetol. 2019;56:777–84. doi: 10.1007/s00592-019-01310-z. - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
